Cargando…

Human Taste Cells Express ACE2: a Portal for SARS-CoV-2 Infection

Loss and changes in taste and smell are well-reported symptoms of SARS-CoV-2 infection. The virus targets cells for entry by high affinity binding of its spike protein to cell-surface angiotensin-converting enzyme- 2 (ACE2). It was not known whether ACE2 is expressed on taste receptor cells (TRCs) n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doyle, Máire E, Appleton, Ashley, Liu, Qing-Rong, Yao, Qin, Mazucanti, Caio Henrique, Egan, Josephine M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077572/ https://www.ncbi.nlm.nih.gov/pubmed/33907747 http://dx.doi.org/10.1101/2021.04.21.440680

Ejemplares similares

Human Type II Taste Cells Express Angiotensin-Converting Enzyme 2 and Are Infected by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Doyle, Máire E., et al.
Publicado: (2021)

SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
por: Mazucanti, Caio Henrique, et al.
Publicado: (2020)

Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-κB signaling
por: Kim, Yoo, et al.
Publicado: (2020)

Dietary curcumin restores insulin homeostasis in diet-induced obese aged mice
por: Lee, Su-Jeong, et al.
Publicado: (2022)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021)

The Infection and Pathogenicity of SARS-CoV-2 Variant B.1.351 in hACE2 Mice
por: Chen, Qi, et al.
Publicado: (2021)

ACE2-independent infection of T lymphocytes by SARS-CoV-2
por: Shen, Xu-Rui, et al.
Publicado: (2022)

Expression pattern and function of SARS-CoV-2 receptor ACE2
por: Li, Ruiting, et al.
Publicado: (2021)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

ACE2 Expression on the Keratinocytes and SARS-CoV-2 Percutaneous Transmission: Are they Related?
por: Zhu, Ruixuan, et al.
Publicado: (2021)

SARS-CoV-2 Infection and Taste Alteration: An Overview
por: Scotto, Gaetano, et al.
Publicado: (2022)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Vismodegib, an antagonist of hedgehog signaling, directly alters taste molecular signaling in taste buds
por: Yang, Hyekyung, et al.
Publicado: (2015)

An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020)

SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae but Not in Taste Buds or Embryonic Oral Epithelium
por: Wang, Zhonghou, et al.
Publicado: (2020)

Relationship between ENaC Regulators and SARS-CoV-2 Virus Receptor (ACE2) Expression in Cultured Adult Human Fungiform (HBO) Taste Cells
por: Ozdener, Mehmet Hakan, et al.
Publicado: (2022)

Olfactory and Taste Disorders in Patients with SARS-CoV-2 Infection
por: Begam, Nazia, et al.
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, E. P., et al.
Publicado: (2020)

Therapeutic Strategies for SARS-CoV-2 acting on ACE-2
por: Vitiello, A., et al.
Publicado: (2021)

Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
por: Lazartigues, Eric, et al.
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, Emilia P., et al.
Publicado: (2021)

Oral cancer and ACE2 receptor of SARS-CoV-2
por: Martelli-Júnior, Hercílio, et al.
Publicado: (2020)

Endocrine significance of SARS-CoV-2’s Reliance on ACE2
por: Chappell, Mark C
Publicado: (2020)

ACE2, SARS-CoV-2 und RAAS-Blocker
por: Kintscher, Ulrich, et al.
Publicado: (2021)

ACE2-Independent Alternative Receptors for SARS-CoV-2
por: Lim, Suhyeon, et al.
Publicado: (2022)

SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
por: Datta, Prasun K., et al.
Publicado: (2020)

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Novel Human Insulin Isoforms and Cα-Peptide Product in Islets of Langerhans and Choroid Plexus
por: Liu, Qing-Rong, et al.
Publicado: (2021)

The functional motif of SARS-CoV S protein involved in the interaction with ACE2
por: Zhang, Yi, et al.
Publicado: (2009)

SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig
por: Li, Yujun, et al.
Publicado: (2020)

Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2
por: Bhattacharjee, Maloyjo Joyraj, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
por: Wu, Canhao, et al.
Publicado: (2022)

Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
por: Mou, Huihui, et al.
Publicado: (2020)

ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV
por: Lubbe, Lizelle, et al.
Publicado: (2020)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
por: Saponaro, Federica, et al.
Publicado: (2020)

Outsmarting SARS-CoV-2 by empowering a decoy ACE2
por: Sokolowska, Milena
Publicado: (2020)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

Sars-CoV-2 and black population: ACE2 as shield or blade?
por: Vinciguerra, Mattia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6d7l5m29oqvu3qvfgfllkegvkl